FDA Inspection 1089625 — Aizant Drug Research Solutions Private Ltd.
The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on Mar 15, 2019 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE